Our recent review summarizes the role of neuroplastin and its binding partners in molecular pathways underlying neuropsychiatric and neurodegenerative diseases such as schizophrenia, depression, or Alzheimer’s disease (Lin et al., 2021b). Here, NPTN is linked to schizophrenia.